Psychiatry, American Board of Psychiatry & Neurology.
Addiction Psychiatry, Subspecialty Certification.
Forensic Psychiatry, Subspecialty Certification.
1993 – 1995
Psy.D. (Doctor of Clinical Psychology), 1995: Institute for
Contemporary Psychoanalysis, LA, CA.
1988 – 1993
Candidate: Los Angeles Psychoanalytic Institute.
1988 – 1989
Fellow: University of Southern California Medical Center Anxiety
Disorders & Behavior Therapy Clinic.
1985 – 1988
Resident: UCLA Neuropsychiatric Institute.
1980 – 1984
M.D., 1984: University of California, Irvine.
1975 – 1980
B.A. with High Honors, Pharmacology, 1980: UCSB.
1977 – 1977
Institute for Shipboard Education, Semester at Sea Program;
Intensive cross-cultural immersion.
Clinical Professor: UCLA.
Assistant/Associate Clinical Professor: UCLA.
Distinguished Fellow: American Psychiatric Association.
Founding Director: UCLA Social & Performance Anxiety Clinic.
Associate Director of the UCLA Anxiety Disorders Clinic.
President: Southern California Psychiatry Society.
Reviewer: The American Journal of Psychiatry
Advisory Board Member: International Paruresis Association
Selectee: Best Doctors of America, Anxiety Disorders Category, Best Doctors, Inc.
Selectee: Anxiety Disorders Category, Guide to America’s Top Psychiatrists; Consumers Research Council of America
Selectee: Super Doctors; Superdoctors.com
Biographee: Marquis Who’s Who in America, 55th Edition
Editor: Newsletter of the Psychiatric Clinical Faculty Assn, UCLA
Board of Directors: Psychiatric Clinical Faculty Assn, UCLA.
Faculty: Institute for Contemporary Psychoanalysis.
Member: New Center for Psychoanalysis.
Member: St John’s Hospital Alumni Association
1997 – 1999
Process Group Leader: UCLA Neuropsychiatric Institute Residency
1992 – 1995
Chairman: Santa Monica Rotary Polio Eradication Committee
1993 – 1997
Board of Directors: NCCJ (A Human Relations Organization)
Member: Anxiety and Depression Association of America and
Obsessive Compulsive Disorder Foundation
Flying Samaritans Member: a group of doctors and pilots who fly to isolated rural areas of Mexico to provide medical treatment.
Principal Investigator: Levetiracetam (N-type calcium channel
blocker) in the treatment of social phobia: UCB Pharma grant.
Co-Investigator: Fluoxetine and Olanzapine in the treatment of
treatment-resistant depression: Lilly grant.
Co-Investigator: Sigma opioid receptor agonist in the treatment of
depression: Otsuka grant.
Principal Investigator: Substance P Antagonist in the
treatment of social phobia: Novartis grant.
Co-Investigator: Lamotrigine in the treatment of bipolar
depression: Glaxo Wellcome grant.
Principal Investigator: Brofaromine (Reversible MAO B Inhibitor)
in the treatment of social phobia. Ciba-Geigy grant.
Lab Technician: Prepared and operated guinea pig atrium and
ileum live-tissue assays to screen compounds isolated from marine
organisms for potential pharmacologic activity.
Sea Grant Project.